INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 11,860
+50 (0.42%)
At close: Jan 29, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 116.82 billion as of January 30, 2026. Its market cap has increased by 63.18% in one year.
Market Cap
116.82B
Enterprise Value
116.54B
Revenue
7.80B
Ranking
n/a
PE Ratio
4.47
Stock Price
11,860.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 116.82B, a decrease of -46.51%. That is a compound annual growth rate of -3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 116.82B | 11.53% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Au Brandz Co.,Ltd | 368.16B |
| JS Corporation | 345.59B |
| Hwaseung Enterprise | 302.95B |
| BAIKSAN Co,. | 258.42B |
| HWASEUNG Industries | 161.01B |
| Samyang Tongsang | 153.38B |
| The Nature Holdings | 116.47B |
| Uni-Chem | 107.79B |